08:20 AM EDT, 10/28/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.

Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.

Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.

Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.

Price: 3.8500, Change: -0.39, Percent Change: -9.20